Low Thyroid Symptoms: What Could Be Causing Them and What to Do Next

Why Your Thyroid Might Be Underperforming

The thyroid gland sits at the base of the neck and produces two hormones, thyroxine (T4) and triiodothyronine (T3), that regulate metabolism in virtually every cell. When production drops, the body slows down. Fatigue sets in. Weight creeps up without dietary changes. Skin dries out, hair thins, and cold rooms become unbearable.

The Hypothalamic-Pituitary-Thyroid Axis

Thyroid hormone production follows a feedback loop. The hypothalamus releases TRH, which signals the pituitary to release TSH, which then tells the thyroid to make T4 and T3 1. A failure at any point along this axis produces low thyroid symptoms. Primary hypothyroidism (the thyroid gland itself failing) accounts for over 95% of cases, while central hypothyroidism (pituitary or hypothalamic dysfunction) is rare, occurring in roughly 1 in 80,000 to 1 in 120,000 people 2.

Recognizing the Pattern

Symptoms cluster in predictable ways. The 2014 European Thyroid Association (ETA) guideline on subclinical hypothyroidism noted that "fatigue, weight gain, constipation, dry skin, and depression are the most frequently reported symptoms, though none is specific to hypothyroidism" 3. That overlap with other conditions is exactly why blood work, not symptom checklists alone, drives the diagnosis.

Hashimoto's Thyroiditis: The Leading Cause

Autoimmune thyroiditis, commonly called Hashimoto's disease, is responsible for approximately 90% of hypothyroidism cases in iodine-replete populations 4. The immune system generates antibodies (anti-TPO and anti-thyroglobulin) that attack thyroid tissue, gradually destroying the gland's ability to produce hormones.

Who Gets Hashimoto's

Women develop Hashimoto's at 5 to 10 times the rate of men 5. Peak incidence occurs between ages 30 and 50, though the disease can appear at any age. A family history of autoimmune conditions (type 1 diabetes, celiac disease, rheumatoid arthritis) raises risk substantially. The NHANES III survey found anti-TPO antibodies in 13% of the U.S. Population, with prevalence increasing with age 6.

Progression and Timeline

The destruction is gradual. Many patients spend years in a subclinical phase where TSH is mildly elevated but free T4 remains normal. The Whickham Survey, a landmark 20-year follow-up of 2,779 adults in the U.K., found that women with elevated TSH and positive anti-TPO antibodies had a 4.3% annual risk of progressing to overt hypothyroidism 7. Without antibodies, the annual progression rate dropped to 2.6%.

Confirming the Diagnosis

A TSH above 10 mIU/L paired with a low free T4 confirms overt hypothyroidism. Anti-TPO antibody testing identifies Hashimoto's as the underlying cause. The American Thyroid Association (ATA) recommends checking anti-TPO antibodies when TSH is elevated to guide treatment decisions in subclinical cases 8.

Other Causes Your Doctor Should Rule Out

Hashimoto's dominates the differential, but several other conditions produce identical symptoms and require different management.

Iodine Deficiency

Globally, iodine deficiency remains the most common cause of hypothyroidism, affecting an estimated 2 billion people 9. In the United States, universal salt iodization has made severe deficiency rare. But mild iodine insufficiency persists in certain populations. A 2012 CDC analysis found that 35.3% of pregnant women in the U.S. Had urinary iodine concentrations below the WHO adequacy threshold 10. The fix is dietary, not pharmaceutical, in most mild cases.

Medication-Induced Hypothyroidism

Several widely prescribed drugs damage thyroid function through distinct mechanisms:

• Amiodarone contains 75 mg of iodine per 200 mg tablet (far exceeding the 150 mcg daily requirement) and causes hypothyroidism in 5 to 22% of treated patients 11.
• Lithium concentrates in the thyroid, inhibiting hormone release. Hypothyroidism develops in 6 to 52% of lithium-treated patients depending on duration and pre-existing antibody status 12.
• Immune checkpoint inhibitors (nivolumab, pembrolizumab, ipilimumab) trigger thyroid inflammation in 5 to 10% of patients receiving anti-PD-1 therapy 13.

Post-Treatment Hypothyroidism

Radioactive iodine (RAI) ablation for Graves' disease or thyroid cancer results in permanent hypothyroidism in 80 to 90% of patients within the first year 14. Total thyroidectomy causes hypothyroidism in 100% of cases. Even hemithyroidectomy (removing half the gland) leads to hypothyroidism in 22 to 35% of patients, requiring lifelong levothyroxine in a meaningful fraction 15.

Postpartum Thyroiditis

Between 5% and 10% of women develop postpartum thyroiditis within 12 months of delivery 16. The condition typically follows a biphasic course: a transient thyrotoxic phase at 2 to 6 months postpartum, followed by a hypothyroid phase at 4 to 8 months. Most recover, but 20 to 30% develop permanent hypothyroidism within 10 years.

Central Hypothyroidism

Pituitary tumors, pituitary surgery, traumatic brain injury, and infiltrative diseases like sarcoidosis can impair TSH secretion. The giveaway is a low or inappropriately normal TSH alongside a low free T4. This pattern requires pituitary MRI and additional hormone testing. Standard TSH-first screening algorithms miss central hypothyroidism entirely.

How Low Thyroid Symptoms Are Diagnosed

Diagnosis follows a stepwise laboratory approach. Clinical suspicion alone is insufficient because symptoms overlap heavily with depression, iron deficiency anemia, sleep apnea, and perimenopause.

The TSH-First Strategy

The ATA and the American Association of Clinical Endocrinologists (AACE) both recommend serum TSH as the initial screening test 8. TSH is exquisitely sensitive to small changes in circulating thyroid hormone. A doubling of TSH often reflects only a 10 to 15% decline in free T4.

Normal TSH ranges vary slightly by laboratory, but 0.4 to 4.0 mIU/L is standard for non-pregnant adults. The reference range shifts upward with age. The NHANES III dataset showed that the 97.5th percentile for TSH in adults aged 70 to 79 was 5.9 mIU/L compared with 4.2 mIU/L for those aged 20 to 29 6.

When Free T4 and Antibodies Matter

If TSH is elevated, free T4 determines severity:

| TSH | Free T4 | Diagnosis | |---|---|---| | >4.0 mIU/L | Normal | Subclinical hypothyroidism | | >10 mIU/L | Low | Overt hypothyroidism | | Normal or low | Low | Central hypothyroidism (rare) |

Anti-TPO antibodies should be checked when TSH is between 4.5 and 10 mIU/L to help predict progression and inform treatment timing 8.

What Else to Check

Iron studies, vitamin B12, a complete metabolic panel, and a morning cortisol level help exclude conditions that mimic hypothyroidism. Sleep apnea screening (Epworth Sleepiness Scale, home sleep study) is reasonable when fatigue is the dominant complaint, given that obstructive sleep apnea affects 17% of men and 9% of women in the general population 17.

Treatment: What Works and What the Evidence Shows

Levothyroxine (synthetic T4) has been the standard of care for hypothyroidism since the 1960s. It is the most prescribed medication in the United States, with over 100 million prescriptions dispensed annually 18.

Starting Levothyroxine

The ATA recommends a weight-based starting dose of 1.6 mcg/kg/day for overt hypothyroidism in otherwise healthy adults younger than 60 8. For a 70 kg person, that works out to approximately 112 mcg daily. Older adults and those with cardiac disease start lower, at 25 to 50 mcg daily, with gradual titration every 6 to 8 weeks.

The medication should be taken on an empty stomach, 30 to 60 minutes before breakfast, with water only. Coffee, calcium supplements, and proton pump inhibitors all impair absorption when taken concurrently 19.

Monitoring and Dose Adjustment

TSH should be rechecked 6 to 8 weeks after any dose change. The goal for most adults is a TSH between 0.5 and 2.5 mIU/L, though optimal targets vary by age and clinical context. Dr. Elizabeth Pearce, former president of the American Thyroid Association, has stated that "the goal of levothyroxine therapy is to normalize TSH, not to chase a specific number within the reference range" 8.

Once stable, annual TSH monitoring is sufficient. Dose requirements may change with weight fluctuations, pregnancy, aging, or new medications that alter absorption or metabolism.

The T3 Debate

Some patients on levothyroxine report persistent symptoms despite normal TSH levels. This has fueled interest in combination T4/T3 therapy (adding liothyronine to levothyroxine). A 2006 meta-analysis of 11 randomized controlled trials involving 1,216 patients found no consistent benefit of combination therapy over T4 monotherapy for quality of life, mood, or cognitive function 20. The ATA 2014 guidelines acknowledge that combination therapy "may be considered as an experimental approach in compliant patients with hypothyroidism who have persistent symptoms despite adequate TSH levels on LT4 monotherapy" but do not endorse it as routine practice 8.

Subclinical Hypothyroidism: Treat or Watch?

The decision to treat subclinical hypothyroidism (TSH 4.5 to 10 mIU/L, normal free T4) depends on clinical context. The TRUST trial (N=737), published in the New England Journal of Medicine in 2017, randomized adults aged 65 and older with subclinical hypothyroidism to levothyroxine or placebo. At 12 months, there was no difference in thyroid-related quality of life scores or tiredness between groups 21.

Treatment is generally recommended when TSH exceeds 10 mIU/L, when anti-TPO antibodies are positive, during pregnancy or in women planning conception, or when symptoms are clearly attributable. The 2023 ETA guideline on subclinical hypothyroidism in older adults (age >65) advises against routine treatment when TSH is below 10 mIU/L 22.

Lifestyle Factors That Influence Thyroid Function

Medication alone does not fully address low thyroid symptoms for every patient. Modifiable factors play a real role.

Nutrient Status

Selenium, zinc, and iron all participate in thyroid hormone synthesis and conversion. A 2013 Cochrane review found limited evidence that selenium supplementation reduces anti-TPO antibody levels in Hashimoto's patients, but the clinical significance of this antibody reduction remains unclear 23. Iron deficiency impairs thyroid peroxidase activity. Correcting iron deficiency in hypothyroid patients on levothyroxine improved TSH normalization rates in a 2009 study of 60 women with both conditions 24.

Gut Health and Absorption

Celiac disease, atrophic gastritis, and Helicobacter pylori infection all reduce levothyroxine absorption. Screening for celiac disease is reasonable in hypothyroid patients who require unusually high doses or whose TSH remains elevated despite apparent adherence. The prevalence of celiac disease in autoimmune thyroid disease patients is 2 to 5%, compared with roughly 1% in the general population 25.

Stress and Sleep

Chronic sleep deprivation alters TSH secretion patterns. A study of 24 healthy men kept awake for 88 hours showed a 30% suppression of TSH amplitude 26. While poor sleep does not cause Hashimoto's, it worsens fatigue in patients already managing hypothyroidism and complicates the clinical picture.

When to Seek Specialist Care

Most hypothyroidism is straightforward. A primary care physician diagnoses it, prescribes levothyroxine, and monitors TSH. Referral to an endocrinologist is warranted in specific scenarios.

Red Flags for Referral

• A thyroid nodule found on palpation or imaging (present in up to 68% of adults on high-resolution ultrasound) 27
• Central hypothyroidism suspected (low TSH with low free T4)
• Persistent symptoms despite TSH in the goal range for 6+ months
• Hypothyroidism during pregnancy (TSH targets shift to trimester-specific ranges)
• Difficulty stabilizing TSH despite dose adjustments and adherence

Dr. Victor Bernet, past president of the American Thyroid Association, has noted that "the most common reason for referral is persistent symptoms with normal labs, which requires careful evaluation for non-thyroidal causes before attributing them to the thyroid" 8.

Pregnancy and Thyroid Function

Pregnancy increases thyroid hormone demand by 30 to 50%. The ATA recommends a TSH target of <2.5 mIU/L in the first trimester and <3.0 mIU/L in subsequent trimesters 8. Women on levothyroxine should increase their dose by approximately 30% as soon as pregnancy is confirmed and have TSH checked every 4 weeks during the first half of pregnancy.

Untreated maternal hypothyroidism is associated with increased risk of preeclampsia, placental abruption, and impaired neurodevelopment in offspring. A 1999 study in the New England Journal of Medicine found that children of women with untreated hypothyroidism during pregnancy scored 7 points lower on IQ testing at age 7 to 9 compared with children of euthyroid mothers (N=62 hypothyroid, N=124 controls) 28.